|
|
???tair.name??? >
???browser.page.title.author???
|
"徐志宏"???jsp.browse.items-by-author.description???
Showing items 61-110 of 154 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2012 |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao, Y-Y; Lu, L-C; Lin, Z-Z; Hsu, C.; Shen, Y-C; Hsu, C-H; Cheng, A-L; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立臺灣大學 |
2012 |
THE ROLES OF GROWTH ARREST DNA DAMAGE-INDUCIBLE GENE 45 Gamma (GADD45 Gamma) EXPRESSION IN SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC) CELLS
|
Hsu, C.; Ou, D. -L.; Shiau, C. -W.; Fan, H. -H.; Liao, S. -C.; Lin, Y. -Y.; Hsu, C. -H.; Cheng, A. -L.; 林育誼; 鄭安理; 徐志宏; 許駿; 歐大諒 |
| 國立臺灣大學 |
2012 |
Dissimilar Immunohistochemical Expression of ERK and AKT between Paired Biopsy and Hepatectomy Tissues of Hepatocellular Carcinoma
|
Shao, Yu-Yun; Chen, Chi-Long; Ho, Ming-Chih; Huang, Chien-Chung; Tu, Hui-Ching; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 何明志 |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study
|
Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Tzen, Kai-Yuan; Cheng, Jason C.; Lee, Jang-Ming; Wang, Hsiu-Po; Huang, Pei-Ming; Hsu, Feng-Ming; Chen, Wei-Wu; Huang, Ta-Chen; Cheng, Ann-Lii; 林家齊; 曾凱元; 鄭安理; 成佳憲; 黃大成; 徐志宏; 李章銘; 王秀伯; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
LOW FREQUENCIES OF BRAF AND B-CATENIN (CTNNB1) MUTATIONS IN ADVANCED HEPATOCELLULAR CARCINOMA
|
Lu, L. -C.; Shao, Y. -Y.; Hsieh, M. -S.; Huang, C. -C.; Cheng, A. -L.; Hsu, C. -H.; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書 |
| 臺大學術典藏 |
2012 |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Yen, T. -J.;Chung, C. -S.;Wu, Y. -W.;Yen, R. -F.;Cheng, M. -F.;Lee, J. -M.;Hsu, C. -H.;Chang, Y. -L.;Wang, H. -P.; 吳彥雯 ;張逸良 ;顏若芳 ;徐志宏 ;李章銘 ;王秀伯 ;鄭媚方; 吳彥雯 ;張逸良 ;顏若芳 ;徐志宏 ;李章銘 ;王秀伯 ;鄭媚方; Yen, T. -J.; Yen, T. -J.; Chung, C. -S.; Chung, C. -S.; Wu, Y. -W.; Yen, R. -F.; Yen, R. -F.; Cheng, M. -F.; Lee, J. -M.; Hsu, C. -H.; Chang, Y. -L.; Wang, H. -P.; 張逸良; 張逸良 |
| 國立臺灣海洋大學 |
2011-06 |
建構綠色供應鏈供應商採購之績效評比模式
|
徐志宏;梁金樹 |
| 國立臺灣海洋大學 |
2011 |
流通服務業發展綠色供應鏈動態績效評價系統之研究－從國際物流觀點
|
Chih-Hung Hsu; 徐志宏 |
| 中國文化大學 |
2010 |
新竹市北門大街再生之研究
|
徐志宏 |
| 國立臺灣大學 |
2010 |
Combinations of Mtorc1 Inhibitor Rad001 with Gemcitabine and Paclitaxel for Treating Non-Hodgkin Lymphoma
|
江俊德; 葉培彥; 高明; 郭頌鑫; 徐志宏; 盧彥伸; 鄭安理; CHIANG, CHUN-TE; YEH, PEI-YEN; GAO, MING; KUO, SUNG-HSIN; HSU, CHIH-HUNG; LU, YEN-SHEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients with Advanced Hepatocellular Carcinoma
|
邵幼雲; 林宗哲; 許駿; 沈盈君; 徐志宏; 鄭安理; SHAO, YU-YUN; LIN, ZONG-ZHE; HSU, CHIUN; SHEN, YING-CHUN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Efficacy and Tolerability of Bevacizumab Plus Capecitabine as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
|
徐志宏; 許駿; 陳培哲; 林宗哲; 趙祖怡; 鄭安理; HSU, CHIH-HUNG; HSU, CHIUN; CHEN, PEI-JER; LIN, ZONG-ZHE; CHAO, TSU-YI; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (Dce-Mri) to Predict Treatment Outcomes for Advanced Hepatocellular Carcinoma (Hcc) Patients Who Received Sorafenib Plus Tegafur/Uracil Therapy
|
沈盈君; 許昭禹; 游治維; 許駿; 徐志宏; 鄭安理; 施庭芳; SHEN, YING-CHUN; HSU, CHAO-YU; YU, CHIH-WEI; HSU, CHIUN; HSU, CHIH-HUNG; CHENG, ANN-LII; SHIH, TIFFANY TING-FANG |
| 國立臺灣大學 |
2010 |
Modulation of Human Ump/Cmp Kinase Affects Activation and Cellular Sensitivity of Deoxycytidine Analogs
|
劉界元; 徐志宏; 張瑋玲; 黃煜珺; 鄭永齊; LIOU, JIEH-YUAN; HSU, CHIH-HUNG; CHANG, WEI-LING; HUANG, YU-CHUN; CHENG, YUNG-CHI |
| 國立臺灣大學 |
2010 |
Phase Ii Study of Combining Sorafenib with Metronomic Tegafur/Uracil for Advanced Hepatocellular Carcinoma
|
徐志宏; 沈盈君; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 許駿; 鄭安理; HSU, CHIH-HUNG; SHEN, YING-CHUN; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
The Aurora Kinase Inhibitor Ve-465 Has Anticancer Effects in Pre-Clinical Studies of Human Hepatocellular Carcinoma
|
許輝吉; 徐志宏; 葉培彥; 黃繼瑩; 郭頌鑫; 許駿; 胡賦強; 鄭永銘; 鄭安理; HSU, HEY-CHI; HSU, CHIH-HUNG; YEH, PEI-YEN; HUANG, CHI-YING; KUO, SUNG-HSIN; HSU, CHIUN; HU, FU-CHANG; JENG, YUNG-MING; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Bevacizumab (B) and Erlotinib (E) in Combination for Asian Patients (Pts) with Advanced/Metastatic Hepatocellular Carcinoma ( Hcc): An Interim Safety Report
|
徐志宏; 邱宗傑; 許駿; 鄭安理; HSU, CHIH-HUNG; CHIOU, TZEON-JYE; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Sorafenib in Combination with Tegafur/Uracil (Uft) for Asian Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 許駿; 徐志宏; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; HSU, CHIUN; HSU, CHIH-HUNG; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Trial of Thalidomide Plus Tegafur/Uracil for Patients with Advanced/Metastatic Hepatocellular Carcinoma (Hcc): Final Report
|
徐志宏; 林宗哲; 沈盈君; 許駿; 鄭安理; HSU, CHIH-HUNG; LIN, ZONG-ZHE; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complications in Esophageal Cancer Patients Receiving Intensity- Modulated Radiation Therapy and Concurrent Chemotherapy Followed by Thoracic Esophagectomy
|
許峰銘; 李元麒; 李章銘; 徐志宏; 林家齊; 蔡育傑; 吳簡坤; 成佳憲; HSU, FENG-MING; LEE, YUNG-CHIE; LEE, JANG-MING; HSU, CHIH-HUNG; LIN, CHIA-CHI; TSAI, YU-CHIEH; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2009 |
Disseminated Peritoneal Leiomyomatosis Responds to Systemic Chemotherapy
|
林育靖; 魏凌鴻; 孫家棟; 鄭安理; 徐志宏; LIN, YU-CHIN; WEI, LIN-HUNG; SHUN, CHIA-TUNG; CHENG, ANN-LII; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2009 |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
林家齊; 徐志宏; 成佳憲; 黃昭淵; 蔡育傑; 許峰銘; 黃國皓; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; CHENG, JASON CHIA- HSIEN; HUANG, CHAO-YUAN; TSAI, YU-CHIEH; HSU, FENG -MING; HUANG, KUO-HOW; CHENG, ANN-LII; PU, YEONG- SHIAU |
| 國立臺灣大學 |
2009 |
Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy
|
林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer
|
葉坤輝; 徐志宏; 許駿; 林璟宏; 沈盈君; 邱宗傑; 趙毅; 鄭安理; YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII |
| 中國醫藥大學 |
2008-12-31 |
台灣金絲桃屬植物組織培養及活性成份之研究
|
徐志宏; 李孟修(Meng-Shiou Lee); 郭昭麟(Kuo Chao-Lin) |
| 修平科技大學 |
2008-10-01 |
應用資料挖礦技術和失效模式與效應分析提升精密鎖具產業製程階段之品質矯正預防改善系統
|
徐志宏;張燦明 |
| 修平科技大學 |
2008-09 |
結合品質機能展開與模糊迴歸分析於滿足顧客需求之新鑽孔機設計
|
徐志宏; 王士元; 張燦明; 陳建佑; 陳翰威; 柯力航; 廖英傑; 邱炫璁 |
| 國立臺灣大學 |
2008-07-31 |
以「針對PI3K/Akt/mTOR訊號徑路的靶向治療藥物」治療肝細胞癌之研究—著重臨床應用性及其可能分子機轉的探討 （新制多年期第2年）
|
徐志宏 |
| 修平科技大學 |
2008-07-01 |
結合統計模式與圍度比為基礎之體型分類技術提升工業尺碼標準設計
|
徐志宏 |
| 國立高雄師範大學 |
2008-06-21 |
民營化後員工工作投入、工作滿足與離職傾向相關性分析─以中華電信南區分公司為例
|
徐志宏; Chih-Hung Hsu |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 修平科技大學 |
2008-03 |
網路電話服務品質顧客滿意度之研究
|
張燦明; 徐志宏; 陳義分; 曾怡燁; 李銀騏 |
| 修平科技大學 |
2008-03 |
以工作研究法提升木業家具製程效益
|
徐志宏; 張燦明; 李子元; 王昱仁; 江建志; 劉依錦; 邱欣怡 |
| 修平科技大學 |
2008-03 |
應用模糊綜合評鑑分析於管理科系本位課程規劃之等級評估
|
徐志宏; 郭輝明; 王士元; 徐佳佑; 楊朝全; 侯宏易; 徐萱齡; 李信良; 吳晨宇 |
| 國立臺灣大學 |
2008 |
Acute Encephalopathy Following Arsenic Trioxide for Metastatic Urothelial Carcinoma
|
林家齊; 蒲永孝; 徐志宏; 耿孝宜; 鄭安理; 楊志新; LIN, CHIA-CHI; PU, YEONG-SHIAU; HSU, CHIH-HUNG; KENG, HSIAO-YI; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complication in Esophageal Cancer Patients Receiving Intensity Modulated Radiation Therapy Followed by Esophagectomy
|
許峰銘; 吳簡坤; 李元麒; 李章銘; 林家齊; 徐志宏; 蔡育傑; 成佳憲; HSU, FENG-MING; WU, JIAN-KUEN; LEE, YUNG-CHIE; LEE, JANG-MING; LIN, CHIA-CHI; HSU, CHIH-HUNG; TSAI, YU-CHIEH; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Improved Local Control by Surgery and Paclitaxel-Based Chemoradiation for Esophageal Squamous Cell Carcinoma: Results of a Retrospective Non- Randomized Study
|
許峰銘; 林家齊; 李章銘; 張逸良; 徐志宏; 蔡育傑; 李元麒; 成佳憲; HSU, FENG-MING; LIN, CHIA-CHI; LEE, JANG-MING; CHANG, YIH-LEONG; HSU, CHIH-HUNG; TSAI, YU-CHIEH; LEE, YUNG-CHIE; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Osu-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species- Related Autophagy in Hepatocellular Carcinoma
|
高明; 葉培彥; 盧彥伸; 徐志宏; 陳昆鋒; 陳慶士; 郭明良; 鄭安理; GAO, MING; YEH, PEI-YEN; LU, YEN-SHEN; HSU, CHIH-HUNG; CHEN, KUEN-FENG; CHEN, CHING-SHIH; KUO, MIN-LIANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Systemic Therapy for Metastatic Urothelial Carcinoma
|
林家齊; 徐志宏; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2008 |
Weekly 24-Hour Infusional 5-Fluorouracil as Initial Treatment for Advanced Gastric Cancer with Acute Disseminated Intravascular Coagulation
|
黃大成; 葉坤輝; 鄭安理; 徐志宏; HUANG, DA-CHEN; YEH, KUN-HUEI; CHENG, ANN-LII; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2008 |
Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2
|
陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 修平科技大學 |
2007-10-01 |
以資料挖礦技術建構高精密度齒輪製程品質診斷系統
|
徐志宏;張燦明 |
| 修平科技大學 |
2007-09 |
二維品質應用之探討─以台鐵服務品質為例
|
鍾昀璋; 王士元; 徐志宏; 廖建岳 |
| 國立臺灣大學 |
2007-07-31 |
以「針對PI3K/Akt/mTOR訊號徑路的靶向治療藥物」治療肝細胞癌之研究—著重臨床應用性及其可能分子機轉的探討 （新制多年期第1年）
|
徐志宏 |
| 高雄醫學大學 |
2007 |
以低量paclitaxel與高劑量5-fluorouracil 同時結合leucovorin治療賀爾蒙反拗之前列腺癌：In Vitro藥物結合 與臨床phase II 實驗結果
|
林家齊;徐志宏;侯自銓;鄭安理;黃昭淵;黃國皓;陳淳;蒲永孝 ; Lin CC;Hsu CH;Hour TC;Cheng AL;Huang CY;Huang KH;Chen J;Pu YS |
Showing items 61-110 of 154 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
|
